| |
| Issue |
Title |
| |
| No 8 (2025) |
Comorbid patient with gastroesophageal reflux disease: Features of the choice of proton pump inhibitor |
Abstract
PDF (Rus)
|
|
G. B. Selivanova, N. G. Poteshkina |
| |
| No 8 (2025) |
Efficacy and safety of pantoprazole in the treatment of patients with gastroesophageal reflux disease in real-world clinical practice: A multicenter observational study |
Abstract
PDF (Rus)
|
|
I. V. Maev, A. V. Zaborovskiy, L. G. Yurenev, L. A. Tararina, D. V. Yunina, E. G. Lobanova, D. N. Andreev, F. S. Sokolov, E. V. Ulyankina, Yu. A. Lezhneva |
| |
| No 8 (2025) |
Epithelium-protective therapy for patients with autoimmune gastritis with different status of Helicobacter pylori |
Abstract
PDF (Rus)
|
|
A. V. Gubanova, M. A. Livzan, S. I. Mozgovoi |
| |
| No 8 (2025) |
The interaction of Candida albicans and Helicobacter pylori as a probable impossibility of achieving the goals of eradication therapy: A clinical case |
Abstract
PDF (Rus)
|
|
E. P. Kozyr, V. S. Kolomytseva, S. N. Lagutina, O. S. Skuratova |
| |
| No 8 (2025) |
Gastroparesis needs to be detected and treated |
Abstract
PDF (Rus)
|
|
E. Yu. Plotnikova, A. S. Sukhikh |
| |
| No 15 (2024) |
Evaluating the clinical efficacy of therapies in patients with symptoms of gastroesophageal reflux disease after phenotyping based on 24-h pH-impedance monitoring |
Abstract
PDF (Rus)
|
|
I. V. Maev, M. A. Ovsepian, D. N. Andreev, E. V. Barkalova, R. I. Shaburov, L. A. Tararina |
| |
| No 15 (2024) |
Prevalence and clinical features of gastroesophageal reflux disease in residents of the Makhachkala-Caspian agglomeration |
Abstract
PDF (Rus)
|
|
P. N. Akhmedova, N. U. Chamsutdinov |
| |
| No 15 (2024) |
The frequency of symptoms of reflux in the esophagus and triggers of heartburn |
Abstract
PDF (Rus)
|
|
O. V. Shtygasheva, E. S. Ageeva, N. V. Emelyanov |
| |
| No 15 (2024) |
Clinical manifestations of gastroesophageal reflux disease in medical university students |
Abstract
PDF (Rus)
|
|
S. V. Voropaeva, N. K. Shakhova, S. E. Belokon, M. A. Davydova, N. O. Inozemtseva, N. A. Kirgey, E. V. Moskaleva |
| |
| No 15 (2024) |
Pain in the epigastral area: current aspects of differential diagnosis |
Abstract
PDF (Rus)
|
|
D. I. Trukhan, L. V. Tarasova |
| |
| No 8 (2024) |
Gastroesophageal reflux disease as a risk factor of dental hard tissues erosions |
Abstract
PDF (Rus)
|
|
O. O. Yanushevich, I. V. Maev, N. I. Krikheli, Ph. S. Sokolov, D. N. Andreev, M. N. Bychkova, E. G. Lobanova, M. Yu. Starovoytova |
| |
| No 8 (2024) |
Helicobacter pylori infection and dermatological diseases |
Abstract
PDF (Rus)
|
|
D. A. Dudukchyan, D. K. Sarkisyan, D. N. Andreev |
| |
| No 8 (2024) |
Epithelial cell proliferation index in patients with atrophic gastritis depending on the presence of complete or incomplete intestinal metaplasia in the gastric antrum |
Abstract
PDF (Rus)
|
|
R. V. Ryabokon, V. V. Tsukanov, V. A. Khorzhevskii, A. V. Vasyutin, J. L. Tonkikh |
| |
| No 18 (2023) |
Modern aspects of managing patients with non-erosive reflux disease |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, A. V. Vasyutin, Ju. L. Tonkikh |
| |
| No 8 (2023) |
Gastritis and dyspepsia: differentiation as the cornerstone of pharmacotherapy |
Abstract
PDF (Rus)
|
|
D. S. Bordin, M. А. Livzan, Y. А. Kucheryavyy, S. I. Mozgovoi |
| |
| No 8 (2023) |
The role of clarithromycin in modern Helicobacter pylori eradication therapy regimens |
Abstract
PDF (Rus)
|
|
S. Yu. Serebrova, E. N. Kareva, D. O. Kurguzova, E. Yu. Demchenkova, N. N. Eremenko, I. A. Mazerkina, L. M. Krasnуkh, G. F. Vasilenko, A. B. Prokofiev |
| |
| No 8 (2023) |
Optimizing the treatment of patients with gastroesophageal reflux disease: focus on nutritional risk factors and nutritional approaches |
Abstract
PDF (Rus)
|
|
M. A. Ovsepian, E. V. Barkalova, D. N. Andreev, I. V. Maev |
| |
| No 8 (2023) |
Antacids in real clinical practice |
Abstract
PDF (Rus)
|
|
D. I. Trukhan, E. N. Degovtsov, A. Yu. Novikov |
| |
| No 8 (2023) |
Predictors of urgent complications of peptic ulcer |
Abstract
PDF (Rus)
|
|
O. V. Shtygasheva, E. S. Ageeva |
| |
| No 8 (2023) |
New achievements of pharmacology for practical medicine in prevention and therapy of acid-dependent diseases |
Abstract
PDF (Rus)
|
|
S. V. Tikhonov, E. N. Kareva, S. Yu. Serebrova, G. F. Vasilenko, M. K. Vasilyeva, S. A. Makhortova, N. V. Pavlova |
| |
| No 8 (2023) |
Features of stomach and duodenum peptic ulcer in patients with mesenteric atherosclerosis |
Abstract
PDF (Rus)
|
|
A. A. Saenko, A. I. Dolgushina, A. A. Fokin, T. N. Shamaeva, V. V. Genkel, M. V. Tarasov |
| |
| No 8 (2023) |
Current trends in Helicobacter pylori eradication therapy |
Abstract
PDF (Rus)
|
|
D. N. Andreev, D. S. Bordin, K. А. Nikolskaya, A. R. Dzhafarova, V. V. Cherenkova |
| |
| No 15 (2022) |
H. pylori-associated chronic gastritis: status update on the problem |
Abstract
PDF (Rus)
|
|
I. V. Maev, D. N. Andreev, A. A. Samsonov, A. K. Fomenko |
| |
| No 15 (2022) |
Features of diet therapy for H. pylori associated diseases of the gastrointestinal tract |
Abstract
PDF (Rus)
|
|
T. L. Pilat, O. N. Minushkin, L. B. Lazebnik, I. V. Zverkov, Yu. G. Kuznetsova, R. A. Khanferyan |
| |
| No 15 (2022) |
Efficacy of an esophageal mucosal protectant in the treatment of patients with gastroesophageal reflux disease: a systematic review |
Abstract
PDF (Rus)
|
|
I. V. Maev, D. N. Andreev, Yu. A. Kucheryavyy, E. G. Lobanova, D. I. Shefer |
| |
| No 15 (2022) |
Modern opportunities to improve the effectiveness of eradication therapy on a clinical case |
Abstract
PDF (Rus)
|
|
I. G. Pakhomova |
| |
| No 15 (2021) |
Modern approaches to pharmacotherapy of chronic gastritis |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, L. V. Zaklyakova, B. N. Levitan, M. Yu. Bolgova, I. K. Zaklyakov, E. A. Golieva |
| |
| No 15 (2021) |
Laryngopharyngeal reflux diagnostics: review article |
Abstract
PDF (Rus)
|
|
I. B. Angotoeva, A. K. Aylarov, S. Ya. Kosyakov, I. D. Loranskaya, E. E. Rumyantseva |
| |
| No 5 (2021) |
Features of the course of gastric ulcer in different age groups |
Abstract
PDF (Rus)
|
|
E. I. Polozova, V. V. Skvortsov, I. E. Trokhina, N. S. Nefedov |
| |
| No 5 (2021) |
The importance of functional diagnostics in determining the cause of antisecretary therapy inefficiency in a patient with heartburn: clinical observation |
Abstract
PDF (Rus)
|
|
E. V. Barkalova, D. N. Andreev, M. A. Ovsepian |
| |
| No 5 (2021) |
Gastroesophageal reflux disease: new approaches to optimizing pharmacotherapy |
Abstract
PDF (Rus)
|
|
D. N. Andreev, A. V. Zaborovsky, E. G. Lobanova |
| |
| No 15 (2020) |
Pantoprazole niche among the GERD-medicines |
Abstract
PDF (Rus)
|
|
A. K. Starodubtsev, D. O. Kurguzova, E. Yu. Demchenkova, V. N. Drozdov, S. Yu. Serebrova |
| |
| No 5 (2020) |
Clinical efficacy of vitamin-mineral complexes in the treatment of diseases of the gastrointestinal tract |
Abstract
PDF (Rus)
|
|
T. L. Pilat, V. V. Bessonov, M. M. Korosteleva, I. V. Radysh, R. A. Khanferyan |
| |
| No 5 (2020) |
Modern opportunities for treatment and prevention of NSAID-induced enteropathies |
Abstract
PDF (Rus)
|
|
I. A. Viktorova, D. I. Trukhan, D. S. Ivanova |
| |
| No 5 (2020) |
The importance of probiotics in optimizing the efficacy and safety of Helicobacter pylori infection eradication therapy |
Abstract
PDF (Rus)
|
|
D. N. Andreev, I. V. Maev, A. A. Samsonov |
| |
| No 5 (2020) |
Gut dysmotility in functional gastrointestinal disorders. Potential for therapeutic adjustment in terms of clinical case management |
Abstract
PDF (Rus)
|
|
I. G. Pakhomova |
| |
| No 14 (2019) |
Potential use of methylmethionine (vitamin U) as a gastroprotector Interview with Prof. Evgeniya V. Shikh, Dr. of Sci. (Med.), Head of Chair for Clinical Pharmacology and Propaedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| No 14 (2019) |
Comorbid patient with GERD and cardiovascular disease receiving antiplatelet therapy. The possibilities of choosing a proton pump inhibitor on a case study |
Abstract
PDF (Rus)
|
|
I. G. Pakhomova |
| |
| No 14 (2019) |
Gastroesophageal Reflux Disease: Challenge of Our Time. Based on the proceedings of the «Man and Medicine» Congress and 3rd Gastrosammit |
Abstract
PDF (Rus)
|
|
Yu. V. Evsyutina |
| |
| No 14 (2019) |
Gastroesophageal reflux disease: actual aspects of diagnostics and treatment in real clinical practice of therapist |
Abstract
PDF (Rus)
|
|
D. I. Trukhan, I. A. Viktorova |
| |
| No 14 (2019) |
Diabetes mellitus as a cause of inefficiency of eradication therapy of Helicobacter pylori infection: a systematized literature review |
Abstract
PDF (Rus)
|
|
L. G. Bektemirova, D. N. Andreev, A. M. Mkrtumyan, D. T. Dicheva |
| |
| No 3 (2019) |
Laryngopharyngeal reflux: clinical significance, modern approaches to diagnosis and treatment |
Abstract
PDF (Rus)
|
|
I. V. Maev, J. V. Selskaya, D. N. Andreev, D. T. Dicheva, Z. N. Bogolepova, E. I. Kuznetsova |
| |
| No 3 (2019) |
Functional dyspepsia: from pathogenesis to therapeutic aspects |
Abstract
PDF (Rus)
|
|
D. T. Dicheva, Yu. S. Subbotina, L. G. Bektemirova, D. N. Andreev |
| |
| No 3 (2019) |
Sphincter of Oddi dysfunction. Case history |
Abstract
PDF (Rus)
|
|
T. E. Polunina |
| |
| No 3 (2019) |
Choice of protonic pump inhibitor with regard to multimorbidity: a focus on rabeprazol |
Abstract
PDF (Rus)
|
|
D. I. Trukhan, E. N. Degovtsov, A. L. Mazurov |
| |
| No 3 (2019) |
New European guidelines for the management of patients with precancerous changes in the stomach |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, A. V. Vasyutin, J. L. Tonkih, O. V. Peretyatko |
| |
| No 3 (2019) |
Selection of PPI in a comorbid patient with NSAIDgastroesophagopathy: case study |
Abstract
PDF (Rus)
|
|
I. G. Pakhomova |
| |
| No 3 (2019) |
Assessment of efficiency of therapy at patients with the gastroesophageal reflux disease in age aspect |
Abstract
PDF (Rus)
|
|
O. A. Denisova, M. A. Livzan, A. P. Denisov, O. A. Kuhn |
| |
| No 3 (2019) |
Metilmetioninsulfoniya chloride in the complex of therapeutic and prophylactic programs at diseases of gastroduodenal zone |
Abstract
PDF (Rus)
|
|
N. V. Topchiy, A. S. Toporkov |
| |
| No 14 (2018) |
Potential use of methylmethionine sulfonium chloride as a component of combination therapy for peptic ulcer and gastroduodenitis |
Abstract
PDF (Rus)
|
|
I. G. Pakhomova |
| |
| No 14 (2018) |
Octurnal heartburn: there is a solution |
Abstract
PDF (Rus)
|
|
V. I. Simanenko, S. V. Tikhonov, N. B. Lishchuk |
| |
| No 14 (2018) |
Prevalence and modern aspects of the treatment of patients with Barrett’s esophagus |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, A. V. Vasyutin, N. N. Butorin, Yu. L. Tonkikh, O. V. Peretyatko, A. S. Pulikov |
| |
| No 3 (2018) |
Basics of gastric acid secretion |
Abstract
PDF (Rus)
|
|
I. V. Maev, D. N. Andreev, A. V. Zaborovsky |
| |
| No 3 (2018) |
Functional dyspepsia in practice of the doctor-therapist |
Abstract
PDF (Rus)
|
|
S. A. Baranov, V. M. Nechaev |
| |
| No 3 (2018) |
Significance of adequate acid suppression as part of helicobacter pylori-associated disease therapy |
Abstract
PDF (Rus)
|
|
D. N. Andreev, A. M. Veliev |
| |
| No 3 (2018) |
Treatment algorithm for patients with functional dyspepsia from the perspective of current clinical guidelines |
Abstract
PDF (Rus)
|
|
D. N. Andreev |
| |
| No 3 (2018) |
Antisecretory treatment: clear-cut benefit and potential risk |
Abstract
PDF (Rus)
|
|
S. I. Pimanov, E. V. Makarenko, E. A. Dikareva |
| |
| No 3 (2018) |
The strategy for choosing a new-generation proton pump inhibitor dexlansoprazole in the treatment of gastroesophageal reflux disease |
Abstract
PDF (Rus)
|
|
N. V. Topchiy, A. S. Toporkov |
| |
| No 15 (2017) |
OPTIMIZED ERADICATION PROTOCOLS: RECOMMENDATIONS OF THE AMERICAN GASTROENTEROLOGIST BOARD, MASSTRIKHT v/FLORENTINE AND TORONTO CONSENSUSES |
Abstract
PDF (Rus)
|
|
S. I. Pimanov, E. V. Makarenko |
| |
| No 15 (2017) |
USE OF BISMUTH DRUGS IN THERAPY OF GASTROENTEROLOGIC PATIENTS AND IN ERADICATION SCHEMES TAKING INTO ACCOUNT MAASTRICHT V RECOMMENDATIONS |
Abstract
PDF (Rus)
|
|
O. N. Minushkin, T. B. Topchiy, A. M. Chebotareva |
| |
| No 15 (2017) |
COMBINATION THERAPY OF EROSIVE FORM OF GERD IN PATIENTS WITH THE MIXED CHARACTER OF RELUCTATE |
Abstract
PDF (Rus)
|
|
D. V. Danilov, A. G. Shuleshova, I. V. Zverkov, K. A. Bondareva |
| |
| No 15 (2017) |
ACTUAL ASPECTS OF ANTI-SECRETOR THERAPY OF GASTROESOPHAGEAL REFLUX DISEASE |
Abstract
PDF (Rus)
|
|
D. I. Trukhan, I. A. Grishechkina |
| |
| No 14 (2016) |
Как помочь больному с функциональным оверлап-синдромом |
Abstract
PDF (Rus)
|
|
V. I. Simanenkov |
| |
| No 14 (2016) |
Use of Rabeprazol in practice of gastroenterologist |
Abstract
PDF (Rus)
|
|
Y. O. Shulpekova |
| |
| No 14 (2016) |
Chronic pancreatitis. New findings |
Abstract
PDF (Rus)
|
|
L. V. Maslovsky |
| |
| No 14 (2016) |
Disturbances of motility of gastrointestinal tract in practice of therapist and some therapeutic approaches |
Abstract
PDF (Rus)
|
|
O. N. Minushkin, L. V. Maslovsky, N. Y. Anikina |
| |
| No 13 (2015) |
Omeprazol in the therapy of acid-base disorders |
Abstract
PDF (Rus)
|
|
O. N. Minushkin, L. V. Maslovskiy |
| |
| No 13 (2015) |
Pathogenesis, diagnosis and treatment of reflux esophagitis in patients after gastric surgery |
Abstract
PDF (Rus)
|
|
O. N. Minushkin, L. V. Maslovskiy, A. G. Shuleshova, N. S. Nazarov |
| |
| No 13 (2015) |
Combined functional disorders (diseases) of the gastrointestinal tract. Diagnostic and treatment approaches |
Abstract
PDF (Rus)
|
|
O. N. Minushkin |
| |
| No 13 (2015) |
Eradication of Helicobacter Pylori |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, E. V. Kasparov, A. V. Vasyutin, Y. L. Tonkikh |
| |
| No 13 (2015) |
Antacids in the modern treatment of acid-base disorders |
Abstract
PDF (Rus)
|
|
O. I. Ivanova, O. N. Minushkin |
| |
| No 13 (2015) |
Autoimmune chronic gastritis - a nosological entity or a syndrome? |
Abstract
PDF (Rus)
|
|
T. B. Topchiy, O. N. Minushkin |
| |
| No 13 (2015) |
Evaluating the effectiveness of a new drug combination in the eradication therapy for duodenal ulcer |
Abstract
PDF (Rus)
|
|
O. N. Minushkin, I. V. Zverkov, D. V. Volodin, O. I. Ivanova |
| |
| 1 - 73 of 73 Items |
|
